| Year |
Citation |
Score |
| 2019 |
Ling SF, Nair N, Verstappen SMM, Barton A, Zucht HD, Budde P, Schulz-Knappe P, Plant D. Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients. The Pharmacogenomics Journal. PMID 31819160 DOI: 10.1038/s41397-019-0139-4 |
0.31 |
|
| 2018 |
Massey J, Plant D, Hyrich K, Morgan AW, Wilson AG, Spiliopoulou A, Colombo M, McKeigue P, Isaacs J, Cordell H, Pitzalis C, Barton A. Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis. The Pharmacogenomics Journal. PMID 30166627 DOI: 10.1038/s41397-018-0040-6 |
0.319 |
|
| 2018 |
Taylor JC, Bongartz T, Massey J, Mifsud B, Spiliopoulou A, Scott IC, Wang J, Morgan M, Plant D, Colombo M, Orchard P, Twigg S, McInnes IB, Porter D, Freeston JE, ... ... Barton A, et al. Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients. The Pharmacogenomics Journal. PMID 29795407 DOI: 10.1038/S41397-018-0025-5 |
0.336 |
|
| 2017 |
Viatte S, Barton A. Genetics of rheumatoid arthritis susceptibility, severity, and treatment response. Seminars in Immunopathology. 39: 395-408. PMID 28555384 DOI: 10.1007/s00281-017-0630-4 |
0.322 |
|
| 2016 |
Sieberts SK, Zhu F, García-García J, Stahl E, Pratap A, Pandey G, Pappas D, Aguilar D, Anton B, Bonet J, Eksi R, Fornés O, Guney E, Li H, Marín MA, ... ... Barton A, et al. Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis. Nature Communications. 7: 12460. PMID 27549343 DOI: 10.1038/Ncomms12460 |
0.303 |
|
| 2016 |
Myrthianou E, Zervou MI, Budu-Aggrey A, Eliopoulos E, Kardassis D, Boumpas DT, Kougkas N, Barton A, Sidiropoulos P, Goulielmos GN. Investigation of the genetic overlap between rheumatoid arthritis and psoriatic arthritis in a Greek population. Scandinavian Journal of Rheumatology. 1-7. PMID 27440135 DOI: 10.1080/03009742.2016.1199734 |
0.324 |
|
| 2016 |
Viatte S, Lee JC, Fu B, Espéli M, Lunt M, De Wolf JN, Wheeler L, Reynolds JA, Castelino M, Symmons DP, Lyons PA, Barton A, Smith KG. Genetic variation in FOXO3 is associated with reductions in inflammation and disease activity in inflammatory polyarthritis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 27214848 DOI: 10.1002/Art.39760 |
0.333 |
|
| 2015 |
Montes A, Perez-Pampin E, Navarro-Sarabia F, Moreira V, de la Serna AR, Magallares B, Vasilopoulos Y, Sarafidou T, Fernández-Nebro A, Del Carmen Ordóñez M, Narváez J, Cañete JD, Marquez A, Pascual-Salcedo D, Joven B, ... ... Barton A, et al. Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: a case-only study. Arthritis Research & Therapy. 17: 63. PMID 25885039 DOI: 10.1186/s13075-015-0571-z |
0.303 |
|
| 2015 |
Diogo D, Bastarache L, Liao KP, Graham RR, Fulton RS, Greenberg JD, Eyre S, Bowes J, Cui J, Lee A, Pappas DA, Kremer JM, Barton A, Coenen MJ, Franke B, et al. TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits. Plos One. 10: e0122271. PMID 25849893 DOI: 10.1371/Journal.Pone.0122271 |
0.302 |
|
| 2014 |
Plant D, Wilson AG, Barton A. Genetic and epigenetic predictors of responsiveness to treatment in RA. Nature Reviews. Rheumatology. 10: 329-37. PMID 24535543 DOI: 10.1038/nrrheum.2014.16 |
0.301 |
|
| 2014 |
Orozco G, Viatte S, Bowes J, Martin P, Wilson AG, Morgan AW, Steer S, Wordsworth P, Hocking LJ, Barton A, Worthington J, Eyre S. Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome-wide association study. Arthritis & Rheumatology (Hoboken, N.J.). 66: 24-30. PMID 24449572 DOI: 10.1002/art.38196 |
0.324 |
|
| 2014 |
Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, Graham RR, Manoharan A, Ortmann W, Bhangale T, Denny JC, ... ... Barton A, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 506: 376-81. PMID 24390342 DOI: 10.1038/Nature12873 |
0.324 |
|
| 2014 |
Mathews RJ, Robinson JI, Battellino M, Wong C, Taylor JC, Eyre S, Churchman SM, Wilson AG, Isaacs JD, Hyrich K, Barton A, Plant D, Savic S, Cook GP, et al. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Annals of the Rheumatic Diseases. 73: 1202-10. PMID 23687262 DOI: 10.1136/annrheumdis-2013-203276 |
0.31 |
|
| 2014 |
Viatte S, Plant D, Han B, Fu B, Yarwood A, Thomson W, Symmons D, Worthington J, Young A, Hyrich K, Morgan A, Wilson A, Isaacs J, Raychaudhuri S, Barton A. OP0190 Personalized Genetic Medicine: Amino Acid Positions 11, 71 and 74 in HLA-DRB1 PREDICT Disease Severity, Treatment Response and Mortality in Rheumatoid Arthritis; Multi-Centre Prospective Cohort Studies Annals of the Rheumatic Diseases. 73: 134.2-134. DOI: 10.1136/Annrheumdis-2014-Eular.3155 |
0.325 |
|
| 2013 |
Zervou MI, Myrthianou E, Flouri I, Plant D, Chlouverakis G, Castro-Giner F, Rapsomaniki P, Barton A, Boumpas DT, Sidiropoulos P, Goulielmos GN. Lack of association of variants previously associated with anti-TNF medication response in rheumatoid arthritis patients: results from a homogeneous Greek population. Plos One. 8: e74375. PMID 24040234 DOI: 10.1371/journal.pone.0074375 |
0.334 |
|
| 2013 |
McAllister K, Yarwood A, Bowes J, Orozco G, Viatte S, Diogo D, Hocking LJ, Steer S, Wordsworth P, Wilson AG, Morgan AW, Kremer JM, Pappas D, ... ... Barton A, et al. Identification of BACH2 and RAD51B as rheumatoid arthritis susceptibility loci in a meta-analysis of genome-wide data. Arthritis and Rheumatism. 65: 3058-62. PMID 24022229 DOI: 10.1002/art.38183 |
0.315 |
|
| 2013 |
Cui J, Stahl EA, Saevarsdottir S, Miceli C, Diogo D, Trynka G, Raj T, Mirkov MU, Canhao H, Ikari K, Terao C, Okada Y, Wedrén S, Askling J, Yamanaka H, ... ... Barton A, et al. Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis. Plos Genetics. 9: e1003394. PMID 23555300 DOI: 10.1371/Journal.Pgen.1003394 |
0.31 |
|
| 2013 |
Viatte S, Plant D, Lunt M, Fu B, Flynn E, Parker BJ, Galloway J, Solymossy C, Worthington J, Symmons DP, Dixey JJ, Young A, Barton A. Investigation of rheumatoid arthritis genetic susceptibility markers in the early rheumatoid arthritis study further replicates the TRAF1 association with radiological damage. The Journal of Rheumatology. 40: 144-56. PMID 23242182 DOI: 10.3899/jrheum.121034 |
0.308 |
|
| 2013 |
Umiċeviċ Mirkov M, Cui J, Vermeulen SH, Stahl EA, Toonen EJ, Makkinje RR, Lee AT, Huizinga TW, Allaart R, Barton A, Mariette X, Miceli CR, Criswell LA, Tak PP, de Vries N, et al. Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 72: 1375-81. PMID 23233654 DOI: 10.1136/Annrheumdis-2012-202405 |
0.328 |
|
| 2012 |
Viatte S, Flynn E, Lunt M, Barnes J, Singwe-Ngandeu M, Bas S, Barton A, Gabay C. Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease. Arthritis Research & Therapy. 14: R239. PMID 23121884 DOI: 10.1186/ar4082 |
0.316 |
|
| 2012 |
Maxwell JR, Marinou I, Kuet KP, Orozco G, Moore DJ, Barton A, Worthington J, Wilson AG. Rheumatoid arthritis-associated polymorphisms at 6q23 are associated with radiological damage in autoantibody-positive RA. The Journal of Rheumatology. 39: 1781-5. PMID 22798268 DOI: 10.3899/jrheum.120144 |
0.303 |
|
| 2012 |
Viatte S, Plant D, Bowes J, Lunt M, Eyre S, Barton A, Worthington J. Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients Annals of the Rheumatic Diseases. 71: 1984-1990. PMID 22661644 DOI: 10.1136/annrheumdis-2011-201225 |
0.333 |
|
| 2012 |
Bluett J, Barton A. What have genome-wide studies told us about psoriatic arthritis? Current Rheumatology Reports. 14: 364-8. PMID 22532288 DOI: 10.1007/s11926-012-0255-5 |
0.309 |
|
| 2012 |
Bowes J, Ho P, Flynn E, Ali F, Marzo-Ortega H, Coates LC, Warren RB, McManus R, Ryan AW, Kane D, Korendowych E, McHugh N, FitzGerald O, Packham J, Morgan AW, ... ... Barton A, et al. Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort. Annals of the Rheumatic Diseases. 71: 1350-4. PMID 22328738 DOI: 10.1136/annrheumdis-2011-200802 |
0.318 |
|
| 2012 |
Hinks A, Cobb J, Sudman M, Eyre S, Martin P, Flynn E, Packham J, Barton A, Worthington J, Langefeld CD, Glass DN, Thompson SD, et al. Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap. Annals of the Rheumatic Diseases. 71: 1117-21. PMID 22294642 DOI: 10.1136/annrheumdis-2011-200814 |
0.324 |
|
| 2012 |
Robinson JI, Carr IM, Cooper DL, Rashid LH, Martin SG, Emery P, Isaacs JD, Barton A, Wilson AG, Barrett JH, Morgan AW. Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis. Human Mutation. 33: 741-9. PMID 22290871 DOI: 10.1002/humu.22031 |
0.302 |
|
| 2012 |
Plant D, Prajapati R, Hyrich KL, Morgan AW, Wilson AG, Isaacs JD, Barton A. Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort. Arthritis and Rheumatism. 64: 665-70. PMID 21952740 DOI: 10.1002/art.33381 |
0.329 |
|
| 2011 |
Eyre S, Ke X, Lawrence R, Bowes J, Panoutsopoulou K, Barton A, Thomson W, Worthington J, Zeggini E. Examining the overlap between genome-wide rare variant association signals and linkage peaks in rheumatoid arthritis Arthritis and Rheumatism. 63: 1522-1526. PMID 21370227 DOI: 10.1002/art.30315 |
0.306 |
|
| 2011 |
Orozco G, Barton A, Eyre S, Ding B, Worthington J, Ke X, Thomson W. HLA-DPB1-COL11A2 and three additional xMHC loci are independently associated with RA in a UK cohort. Genes and Immunity. 12: 169-75. PMID 21293383 DOI: 10.1038/gene.2010.57 |
0.308 |
|
| 2011 |
Hinks A, Martin P, Flynn E, Eyre S, Packham J, Barton A, Worthington J, Thomson W. Subtype specific genetic associations for juvenile idiopathic arthritis: ERAP1 with the enthesitis related arthritis subtype and IL23R with juvenile psoriatic arthritis. Arthritis Research & Therapy. 13: R12. PMID 21281511 DOI: 10.1186/ar3235 |
0.313 |
|
| 2011 |
Plant D, Bowes J, Potter C, Hyrich KL, Morgan AW, Wilson AG, Isaacs JD, Barton A. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci. Arthritis and Rheumatism. 63: 645-53. PMID 21061259 DOI: 10.1002/art.30130 |
0.305 |
|
| 2010 |
Coenen MJ, Enevold C, Barrera P, Schijvenaars MM, Toonen EJ, Scheffer H, Padyukov L, Kastbom A, Klareskog L, Barton A, Kievit W, Rood MJ, Jansen TL, Swinkels D, van Riel PL, et al. Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome. Plos One. 5: e14326. PMID 21179534 DOI: 10.1371/journal.pone.0014326 |
0.312 |
|
| 2010 |
Tan RJ, Gibbons LJ, Potter C, Hyrich KL, Morgan AW, Wilson AG, Isaacs JD, Barton A. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment. Annals of the Rheumatic Diseases. 69: 1029-35. PMID 20444755 DOI: 10.1136/ard.2009.118406 |
0.33 |
|
| 2010 |
Orozco G, Barton A. Update on the genetic risk factors for rheumatoid arthritis. Expert Review of Clinical Immunology. 6: 61-75. PMID 20383892 DOI: 10.1586/eci.09.72 |
0.309 |
|
| 2010 |
Plant D, Thomson W, Lunt M, Flynn E, Martin P, Eyre S, Farragher T, Bunn D, Worthington J, Symmons D, Barton A. The role of rheumatoid arthritis genetic susceptibility markers in the prediction of erosive disease in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology (Oxford, England). 50: 78-84. PMID 20219786 DOI: 10.1093/rheumatology/keq032 |
0.348 |
|
| 2010 |
Robinson JI, Barrett JH, Taylor JC, Naven M, Corscadden D, Barton A, Wilson AG, Emery P, Isaacs JD, Morgan AW. Dissection of the FCGR3A association with RA: increased association in men and with autoantibody positive disease. Annals of the Rheumatic Diseases. 69: 1054-7. PMID 19700393 DOI: 10.1136/ard.2009.110874 |
0.307 |
|
| 2009 |
Hinks A, Eyre S, Ke X, Barton A, Martin P, Flynn E, Packham J, Worthington J, Thomson W. Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis. Annals of the Rheumatic Diseases. 69: 1049-53. PMID 19674979 DOI: 10.1136/ard.2009.110650 |
0.325 |
|
| 2009 |
Barton A, Eyre S, Ke X, Hinks A, Bowes J, Flynn E, Martin P, Wilson AG, Morgan AW, Emery P, Steer S, Hocking LJ, Reid DM, et al. Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes. Human Molecular Genetics. 18: 2518-22. PMID 19359276 DOI: 10.1093/hmg/ddp177 |
0.313 |
|
| 2008 |
Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, Gibbons L, Plant D, Wilson AG, Marinou I, Morgan A, Emery P, Steer S, et al. Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility. Human Molecular Genetics. 17: 2274-9. PMID 18434327 DOI: 10.1093/hmg/ddn128 |
0.324 |
|
| 2008 |
Bowes J, Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford, England). 47: 399-402. PMID 18263596 DOI: 10.1093/rheumatology/ken005 |
0.324 |
|
| 2008 |
Farragher TM, Goodson NJ, Naseem H, Silman AJ, Thomson W, Symmons D, Barton A. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis and Rheumatism. 58: 359-69. PMID 18240242 DOI: 10.1002/art.23149 |
0.304 |
|
| 2006 |
Hinks A, Eyre S, Barton A, Thomson W, Worthington J. Investigation of genetic variation across the protein tyrosine phosphatase gene in patients with rheumatoid arthritis in the UK. Annals of the Rheumatic Diseases. 66: 683-6. PMID 17170052 DOI: 10.1136/ard.2006.060459 |
0.312 |
|
| 2006 |
Eyre S, Bowes J, Spreckley K, Potter C, Ring S, Strachan D, Worthington J, Barton A. Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort. Arthritis and Rheumatism. 54: 3417-22. PMID 17075826 DOI: 10.1002/ART.22166 |
0.307 |
|
| 2004 |
Eyre S, Barton A, Shephard N, Hinks A, Brintnell W, MacKay K, Silman A, Ollier W, Wordsworth P, John S, Worthington J. Investigation of susceptibility loci identified in the UK rheumatoid arthritis whole-genome scan in a further series of 217 UK affected sibling pairs. Arthritis and Rheumatism. 50: 729-35. PMID 15022312 DOI: 10.1002/art.20039 |
0.3 |
|
| 2001 |
Barton A, Eyre S, Myerscough A, Brintnell B, Ward D, Ollier WE, Lorentzen JC, Klareskog L, Silman A, John S, Worthington J. High resolution linkage and association mapping identifies a novel rheumatoid arthritis susceptibility locus homologous to one linked to two rat models of inflammatory arthritis. Human Molecular Genetics. 10: 1901-6. PMID 11555626 DOI: 10.1093/HMG/10.18.1901 |
0.307 |
|
| Show low-probability matches. |